In this article:

Wall Street Analysts Are Bullish on Top Healthcare Picks

In this article:
In this article:

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Aerie Pharma (AERIResearch Report) with bullish sentiments.

Aerie Pharma (AERI)

Needham analyst Serge Belanger assigned a Buy rating to Aerie Pharma on December 27 and set a price target of $22.00. The company’s shares closed last Friday at $7.02.

According to TipRanks.com, Belanger is a 3-star analyst with an average return of 1.9% and a 41.7% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Amphastar Pharmaceuticals, and Collegium Pharmaceutical.

Aerie Pharma has an analyst consensus of Strong Buy, with a price target consensus of $24.00.

See the top stocks recommended by analysts >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AERI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed

In this article:

Latest News Feed